Skip to content

TG Therapeutics TGTX Price / earnings

Price / earnings at other companies

Biogen logo
BiogenBIIB
18.9×+5.4×
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
33.6×-8.3×
Arrowhead Research logo
Arrowhead ResearchARWR
44.6×
Roivant Sciences logo
Roivant SciencesROIV
249.7×+248×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
19.8×-16.3×
AbbVie logo
AbbVieABBV
105.8×+17.5×

Other financials

Income statement

See full
Revenue$204.9M+69.6%
Gross profit$171.4M+62.8%
Operating income$34.8M+304%
Net income$19.8M+291%
EPS (diluted)$0.12+300%

Balance sheet

See full
Cash & equivalents$442.2M+235%
Total debt$753.6M+197%
Total equity$583.1M+146%
Total assets$1.5B+133%

Cash flow

See full
Operating cash flow-$17.9M+37.7%
CapEx$51.0K+104%
Free cash flow-$17.9M+37.6%

Valuation

See full
Market cap$8.15B-14.3%
Enterprise value$8.46B-11.1%
P/S11.6×-13.0×

Profitability

See full
Gross margin83.1%-4.4pp
Operating margin21.3%+5.9pp
Net margin66%+55.8pp
FCF margin-6,328.4%+4,773pp

Returns & leverage

See full
Return on equity112.6%+92.9pp
Debt / equity1.3×+0.2×
Current ratio5.8×+1.8×

Where this comes from

Calculated from TG Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TG Therapeutics's price / earnings?
TG Therapeutics (TGTX) reported price / earnings of 11.5× in Q1 2026.
How has TG Therapeutics's price / earnings changed year-over-year?
TG Therapeutics's price / earnings decreased by 92.7% year-over-year, from 158.2× to 11.5×.
What does price / earnings mean?
How many dollars investors pay for each dollar of the company's annual profit.
How do you interpret price / earnings?
Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
How does price / earnings compare across companies?
Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.